Phibro Animal Health (PAHC) Change in Receivables (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Change in Receivables of $4.8 million for Q1 2026, up 37.64% year-over-year from $3.5 million in Q1 2025, and up 304.71% quarter-over-quarter from -$2.3 million in Q4 2025.
Phibro Animal Health (PAHC) Change in Receivables (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Receivables history runs 14 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 37.64% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $17.0 million (down 58.43% YoY), while the FY2025 annual figure was $55.2 million, up 536.18% from the prior year.
- Change in Receivables for Q1 2026 stood at $4.8 million, up from -$2.3 million in the prior quarter.
- The five-year high for Change in Receivables was $35.0 million in Q4 2024, with the low at -$22.3 million in Q3 2022.
- The 5-year median for Change in Receivables is $4.8 million (2026), against an average of $4.4 million.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables slumped 411.02% in 2022, then jumped 7819.86% in 2024.
- Phibro Animal Health's Change in Receivables stood at $7.5 million in 2022, then slumped by 120.44% to -$1.5 million in 2023, then jumped by 2379.41% to $35.0 million in 2024, then sank by 106.67% to -$2.3 million in 2025, then jumped by 304.71% to $4.8 million in 2026.
- Business Quant data shows PAHC's Change in Receivables at $4.8 million in Q1 2026, -$2.3 million in Q4 2025, and -$11.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | -11.37 Mn |
| Sep 30, 2025 | -11.37 Mn |
| Jun 30, 2025 | 25.96 Mn |
| Jun 30, 2025 | 25.96 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 34.99 Mn |
| Dec 31, 2024 | 34.99 Mn |
| Sep 30, 2024 | -9.21 Mn |
| Sep 30, 2024 | -9.21 Mn |
| Jun 30, 2024 | 11.72 Mn |
| Jun 30, 2024 | 11.72 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Dec 31, 2023 | -1.54 Mn |